Cequent Pharmaceuticals

Early Stage Biopharmaceutical

An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases – from inflammatory diseases to cancer – based on the company’s proprietary technology,...

Founded in 2006
Total money raised: $12.4M

02139 One Kendall Square
Building 700, First Floor


Phone: 617.995.7940

Updated on Feb 13, 2011
Cequent Pharmaceuticals at CrunchBase
Peter Parker President, CEO
Lisa Velardo CFO
Susie Truong Harborth VP Operations
Ted Hibben Chief Business Officer

October, 2009

Cequent Pharmaceuticals raised $3.4M in a Series B round

Xconomy Boston

June, 2007

Cequent Pharmaceuticals raised $9M in a Series A round from Novartis Option Fund, Ampersand Capital Partners, Nexus Medical Partners, and Pappas Ventures

Cequent Pharmaceuticals


Cequent Pharmaceuticals was founded in 2006